Top Markets
Coin of the day
Bloomage BioTechnology Corporation Limited Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited

688363
Rangering i aksjer #5709
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and... Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
Aksjekurs
$5.21
Markedsverdi
$2.49B
Endring (1 dag)
-0.91%
Endring (1 år)
-34.46%
Land
CN
Handel Bloomage BioTechnology Corporation Limited (688363)
Inntekter for Bloomage BioTechnology Corporation Limited (688363)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Bloomage BioTechnology Corporation Limited er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Bloomage BioTechnology Corporation Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$35.45B -
GB
- -
FR
$24.41B -
US
$16.84B -
US
$12.60B -
US